MedCity Influencers

iPhone medical apps a doctor wishes he had (Best of MedCitizens)

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com. Now here's the best of what YOU had to say:

Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who discuss life science current events on MedCityNews.com.

Now here’s the best of what YOU had to say:

This doctor’s best iPhone medical apps (and a wish list). “You may wonder how it was possible that I, who consider using an ATM to be a high level computer operation, could make the iPhone, my phone. I knew I couldn’t fail, despite my trepidation of all things cyber. I had a secret weapon, a ’Plan B’. Actually, I had Plan Z, the most powerful asset that anyone in my situation could hope for. Z stands for Zachy. One sentence will explain all and may provoke screams of envy from those who have no available similar resource.”

Corporate Venture Funds: What’s the Deal? “Even without a venture arm, the big medical device companies often invest in early stage companies directly through their operating units or corporate funds. Early equity investments can translate into a nice discount on an ultimate acquisition. Boston Scientific, one of the few in the category without a venture arm (understandable since not so long ago purging many ’venture-like’ assets post-Guidant acquisition), has made several such investments, includingSadra Medical, where Boston participated in a $19M series B in 2006 and then bought the company in 2010 in a deal worth $450M. Boston’s acquisitions ofIntelect Medical andAsthmatx also followed early strategic investments. But why do the others think a venture arm makes sense? And what are these venture arms doing? Let’s look at a few and see if there are clues.”

More than rivalry at work in Cleveland healthcare. “Clevelanders love a good rivalry – OSU/Michigan, Browns/Steelers, Cavs/Heat – but what’s happening at Cleveland Clinic and University Hospitals is a different ballgame altogether. A healthy dose of competition? Absolutely. But who can argue it hasn’t been good for our region?”

Dear Patients, I Walk the Line. Yours Sincerely, Registered Nurse. “Nurses must sympathize with patients to provide the complete realm of care ethically required of them. When nurses personally relate to a patient’s suffering, sympathy becomes empathy’involving a true sharing of another’s pain.”

New ONC chief Mostashari is logical choice after Blumenthal. David Blumenthal’s role was akin to a startup CEO. He had a small staff, $2 billion to spend quickly/wisely, and a bold vision to improve healthcare quality/safety/efficiency using IT. Now that the ONC staff is hired, the initial regulations are written, and the money is allocated, Farzad must evolve vision and startup into implementation and operations.

presented by
Avatar photo

Chris Seper runs MedCityNews.com and contributes regularly to the site. He is the vice president of healthcare for Breaking Media, MedCity's corporate owners. Reach him at [email protected].

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.